title: Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology.
abstract: A working report from the OMERACT Health Economics Group. The group is working towards creating common standards for economic evaluation in rheumatology and also towards improving the scientific underpinning of economic evaluation, particularly pertaining to the rheumatic diseases. Preliminary recommendations for "reference cases" in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed.
authors.affiliation: Department of Health Sciences Research and Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA. gabriel.sherine@mayo.edu
authors.forename: S E
authors.initials: SE
authors.lastname: Gabriel
authors.forename: P
authors.initials: P
authors.lastname: Tugwell
authors.forename: M
authors.initials: M
authors.lastname: Drummond
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D006801:Humans; D017410:Practice Guidelines as Topic; D015397:Program Evaluation; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000191:economics
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents